Can Weight-Loss Injections Help With Knee Osteoarthritis?

Weight-loss injections have become part of the conversation about treating obesity. For people who also live with knee osteoarthritis, this raises a question: can these medications help relieve pain and make it easier to move?
Studies have shown promising results, particularly with semaglutide in people with obesity and knee osteoarthritis. It helps to understand which benefits have been demonstrated and which questions researchers are still investigating.

How Are Weight Loss and Knee Osteoarthritis Related?
Weight management is an important part of osteoarthritis care for people with overweight or obesity. Losing weight can reduce pain, make everyday activities easier, and improve quality of life.
You do not need to reach an “ideal weight” to start seeing benefits. Clinical guidelines indicate that losing around 5% of your body weight can already help. Greater weight loss, when appropriate and supported by follow-up care, tends to bring additional benefits. For someone who weighs 100 kg, for example, 5% is 5 kg. Combining weight management with exercise is part of the recommended approach.
What Did the Studies on Semaglutide Find?
One of the main studies on this topic was STEP 9, published in The New England Journal of Medicine in 2024. The study followed 407 people with obesity, moderate knee osteoarthritis, and at least moderate pain. For 68 weeks, participants received either a weekly semaglutide injection or a placebo. Both groups received guidance on nutrition and physical activity.
Here are the average results:
Outcome after 68 weeks | Semaglutide | Placebo |
Reduction in body weight | 13,7% | 3,2% |
Reduction in WOMAC pain score (0–100 scale) | 41,7 points | 27,5 points |
Physical function also improved more in the semaglutide group. These are group averages, and individual responses may vary. The manufacturer funded the study.
Do All Weight-Loss Injections Have the Same Effect on the Knee?
Results from one medication cannot yet be generalized to all the others. In a study of liraglutide after an initial period of diet-induced weight loss, participants lost more weight with liraglutide, but their knee pain did not improve significantly more than with placebo. Differences in who took part, how each study was designed, and how much weight participants lost matter when interpreting the findings.

Researchers are also studying tirzepatide specifically in people with obesity and knee osteoarthritis. One question is whether it could reduce the need for knee replacement, also known as knee arthroplasty. The answer will depend on the results of those studies.
Can These Medications Regrow Cartilage?
STEP 9 showed improvements in pain and physical function. Whether semaglutide can regrow cartilage, halt the progression of osteoarthritis, or prevent future surgery remains unproven.
Observational studies have found an association between use of medications in this class and slower cartilage loss and fewer knee surgeries. These studies can identify associations, and further research is needed to determine whether the medications themselves affect the structure of the joint.
Why Muscle Mass Matters During Weight Loss
When you lose weight, you may lose both fat and lean mass. In a tirzepatide substudy, about 75% of the weight lost was fat and 25% was lean mass. Lean mass includes muscle and other tissues. The finding highlights the value of monitoring body composition during treatment.
For people with osteoarthritis, a care plan should include exercises suited to their abilities, with an emphasis on strength and physical function. Nutrition guidance and strength assessments can help keep the focus on walking, getting up from a chair, and managing everyday activities throughout weight loss. Exercise remains a cornerstone of osteoarthritis care.

Who May Benefit?
The strongest evidence discussed here comes from people with both obesity and knee osteoarthritis. Whether an injectable weight-loss medication is appropriate depends on a clinical assessment and whether there is a medical indication for weight management.
That decision also takes into account your health conditions, potential side effects, and ability to continue follow-up care. In STEP 9, gastrointestinal side effects were the most common reason participants stopped treatment due to an adverse event.
Injectable medications offer another option for treating obesity in people who have osteoarthritis. They can be part of an individualized plan that accounts for nutrition, exercise, pain management, and each patient's needs. The aim is to improve health and mobility while setting realistic expectations for treatment.
Final Thoughts
For people with obesity and knee osteoarthritis, managing weight can help ease pain and make it easier to move. Research on semaglutide has shown benefits in both areas. Its effects on cartilage and the need for knee replacement are still being studied. When indicated for weight management, injectable medications can be part of a care plan that includes nutrition, exercise tailored to your abilities, and muscle strengthening.
If you have knee osteoarthritis or recurring knee pain, see an orthopedic specialist. An individual assessment can help identify what's causing your pain and guide treatment based on your health, daily activities, and goals.
About the Author
Dr. Daniel Hidalgo is an orthopedic surgeon and traumatologist who specializes in knee surgery and arthroscopy. He graduated from the Faculdade de Medicina do ABC and completed his residency in orthopedics and traumatology and his training in knee surgery at Santa Casa de São Paulo, where he also served as a clinical preceptor. He complemented his training with a clinical observership at Hôpital de la Croix-Rousse in Lyon, France.
His clinical practice includes the evaluation and treatment of knee osteoarthritis, meniscal and ligament injuries, and other conditions that cause pain and limit function. On this blog, he writes about orthopedics and traumatology to help patients understand their diagnoses and take part in decisions about their treatment.
Learn More
Editorial note. This post was prepared with the assistance of artificial intelligence. Dr. Daniel Hidalgo reviewed the content and takes responsibility for the final version.





Comments